Dr. Peter Rubin
Claim this profileMaineHealth/SMHC Cancer Care and Blood Disorders-Biddeford
Area of expertise
Lung Cancer
Peter Rubin has run 6 trials for Lung Cancer. Some of their research focus areas include:
Non-Small Cell Lung Cancer
Peter Rubin has run 6 trials for Non-Small Cell Lung Cancer. Some of their research focus areas include:
Affiliated Hospitals
MaineHealth/SMHC Cancer Care And Blood Disorders-Biddeford
MaineHealth/SMHC Cancer Care And Blood Disorders-Sanford
Clinical Trials Peter Rubin is currently running
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting
2 awards
Phase 3
27 criteria
Chemotherapy Tailored by ctDNA Status
for Colon Cancer
This trial tests if a blood test for cancer DNA can help decide if colon cancer patients need more treatment after surgery. The test looks for cancer DNA in the blood to predict if the cancer might come back and to guide further treatment.
Recruiting
1 award
Phase 2 & 3
More about Peter Rubin
Clinical Trial Related
6 years of experience running clinical trials · Led 17 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments Peter Rubin has experience with
- Atezolizumab
- Paclitaxel
- Pembrolizumab
- Gemcitabine Hydrochloride
- Carboplatin
- Pemetrexed Disodium
Breakdown of trials Peter Rubin has run
Lung Cancer
Non-Small Cell Lung Cancer
Colon Cancer
Breast Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Peter Rubin specialize in?
Peter Rubin focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage II patients, or patients who are Stage III.
Is Peter Rubin currently recruiting for clinical trials?
Yes, Peter Rubin is currently recruiting for 3 clinical trials in Biddeford Maine. If you're interested in participating, you should apply.
Are there any treatments that Peter Rubin has studied deeply?
Yes, Peter Rubin has studied treatments such as Atezolizumab, Paclitaxel, Pembrolizumab.
What is the best way to schedule an appointment with Peter Rubin?
Apply for one of the trials that Peter Rubin is conducting.
What is the office address of Peter Rubin?
The office of Peter Rubin is located at: MaineHealth/SMHC Cancer Care and Blood Disorders-Biddeford, Biddeford, Maine 04005 United States. This is the address for their practice at the MaineHealth/SMHC Cancer Care and Blood Disorders-Biddeford.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.